CLOV

CLOV

USD

Clover Health Investments Corp. Class A Common Stock

$3.340+0.010 (0.300%)

Real-time Price

Healthcare
Healthcare Plans
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$3.330

High

$3.400

Low

$3.254

Volume

0.44M

Company Fundamentals

Market Cap

1.7B

Industry

Healthcare Plans

Country

United States

Trading Stats

Avg Volume

5.66M

Exchange

NMS

Currency

USD

52-Week Range

Low $0.693Current $3.340High $4.87

AI Analysis Report

Last updated: May 3, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

CLOV: Clover Health Investments Corp. Class A Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: CLOV Generate Date: 2025-05-03 20:26:19

Alright, let's break down what's been going on with Clover Health stock (CLOV) based on the latest information. We'll look at the recent news, check out what the price has been doing, and see what the AI crystal ball is hinting at.

Recent News Buzz - What's the Vibe?

Looking at the news headlines from the past couple of weeks, things seem to lean pretty positive for Clover Health.

First off, there's news about their subsidiary, Counterpart Health, and how using their tech with primary care doctors is linked to better results for patients dealing with congestive heart failure. That's a good sign, suggesting their technology platform, the Clover Assistant, is actually making a difference in patient care.

Then, there's a broader piece talking about how AI in healthcare could unlock billions in market value. This is relevant because Clover Health specifically uses AI through its Clover Assistant platform to help doctors. So, if the AI trend in healthcare is big, Clover is positioned right in the middle of it.

We also saw news about changes to the company's Board of Directors and plans to participate in upcoming investor conferences. Board changes are often just standard corporate stuff, not necessarily good or bad on their own. But going to investor conferences? That usually means the company is actively talking to potential investors, which is generally seen as a positive step.

So, putting it together, the recent news flow feels constructive. It highlights the potential benefits of their core technology and shows the company is engaging with the financial community.

Price Check - What's the Stock Been Doing?

Now, let's look at the stock price itself over the last couple of months. If you glance at the historical data, you'll see that after trading in the $4 range back in February, the price started a noticeable slide through March. It hit lows around the mid-$3 mark.

In April, the price seemed to find a bit of a floor, mostly bouncing around between $3.40 and $3.70, though there was one sharp dip below $3 briefly. More recently, in the last few days of April and early May, the stock has been trading pretty tightly, hovering right around the $3.30 to $3.40 level. The previous day's close was $3.32.

What about the AI's prediction for the very near future? The AI model suggests the price will stay flat today (0.00% change), but then tick up slightly over the next two days, predicting a 1.06% rise tomorrow and a 1.78% rise the day after. This suggests the AI sees a small upward move coming from the current price point.

Outlook & Strategy Ideas - Putting It All Together

So, what does this mix of news, price action, and AI prediction suggest?

The positive news about their tech and the broader AI trend in healthcare provides a potentially favorable backdrop. The price has been weak overall but seems to have settled into a recent range, and the AI is forecasting a modest bounce from here.

Based on this, the current situation might lean towards a 'hold' or perhaps a cautious 'accumulate' stance for those interested in the stock. The price is near the lower end of its recent trading range and close to a potential support level mentioned in the recommendation data ($3.35).

If you were considering getting involved, a potential entry area could be around the current price level, say between $3.30 and $3.40. This aligns with where the stock has been trading recently and where the AI predicts a slight upward move starting.

Thinking about managing risk, the recommendation data suggests a potential stop-loss level around $3.00. This is below the recent trading range and offers some room before cutting losses if the price were to fall further. For taking profits, the recommendation points to $3.40, which is right at the top of the recent tight trading range and aligns somewhat with the AI's short-term upward forecast. It could be a potential near-term target to watch.

Company Context

Just remember, Clover Health is primarily focused on Medicare Advantage plans and uses its technology platform, Clover Assistant, as a key part of its strategy. So, news related to healthcare tech, AI in medicine, and government programs like Medicare are particularly important to watch for this company.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Related News

GlobeNewswire

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") and

View more
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
PR Newswire

New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down...

View more
New Advances in Healthcare AI Could Unlock Billions in Market Opportunity
GlobeNewswire

Clover Health Announces Changes to Board of Directors

WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that after four years of distinguished service, Lee A.

View more
Clover Health Announces Changes to Board of Directors
GlobeNewswire

Clover Health to Participate in Upcoming Investor Conferences

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced its participation in the following investor conferences:

View more
Clover Health to Participate in Upcoming Investor Conferences

AI PredictionBeta

AI Recommendation

Bullish

Updated at: May 3, 2025, 01:07 PM

BearishNeutralBullish

61.9% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
ValueAggressive
Trading Guide

Entry Point

$3.34

Take Profit

$3.40

Stop Loss

$3.00

Key Factors

DMI shows bearish trend (ADX:13.6, +DI:6.1, -DI:9.1), suggesting caution
Current Price is extremely close to support level ($3.35), suggesting strong buying opportunity
Trading volume is 5.4x average (66,122), indicating extremely strong buying pressure
MACD -0.0017 is below signal line 0.0016, indicating a bearish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.